Clinical Trials Details

NRG- BR003 (Breast)

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High- Risk Node-Negative Triple-Negative Invasive Breast Cancer

Clinical Trial Categories

  • Cancers and Other Neoplasms